Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone

NCT00121667 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1462

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Saxagliptin + Metformin
DRUG: Saxagliptin + Metformin
DRUG: Saxagliptin + Metformin
DRUG: Placebo + Metformin
DRUG: Pioglitazone

Sponsor

AstraZeneca